Cover Image

Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis

Original Article from The New England Journal of Medicine - Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

Saved in:
Bibliographic Details
Main Authors: Adams, David B. (Author) , Kristen, Arnt (Author)
Format: Article (Journal)
Language:English
Published: July 5, 2018
In: The New England journal of medicine
Year: 2018, Volume: 379, Issue: 1, Pages: 11-21
ISSN:1533-4406
DOI:10.1056/NEJMoa1716153
Online Access:Verlag, Volltext: https://doi.org/10.1056/NEJMoa1716153
Verlag, Volltext: https://www.nejm.org/doi/10.1056/NEJMoa1716153
Get full text
Author Notes:D. Adams, A. Gonzalez-Duarte, W.D. O’Riordan, C.-C. Yang, M. Ueda, A.V. Kristen, I. Tournev, H.H. Schmidt, T. Coelho, J.L. Berk, K.-P. Lin, G. Vita, S. Attarian, V. Planté-Bordeneuve, M.M. Mezei, J.M. Campistol, J. Buades, T.H. Brannagan III, B.J. Kim, J. Oh, Y. Parman, Y. Sekijima, P.N. Hawkins, S.D. Solomon, M. Polydefkis, P.J. Dyck, P.J. Gandhi, S. Goyal, J. Chen, A.L. Strahs, S.V. Nochur, M.T. Sweetser, P.P. Garg, A.K. Vaishnaw, J.A. Gollob, and O.B. Suhr

MARC

LEADER 00000caa a2200000 c 4500
001 1663508445
003 DE-627
005 20220816140735.0
007 cr uuu---uuuuu
008 190423s2018 xx |||||o 00| ||eng c
024 7 |a 10.1056/NEJMoa1716153  |2 doi 
035 |a (DE-627)1663508445 
035 |a (DE-599)KXP1663508445 
035 |a (OCoLC)1341211623 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Adams, David B.  |d 1950-  |e VerfasserIn  |0 (DE-588)1132276829  |0 (DE-627)887689612  |0 (DE-576)48877022X  |4 aut 
245 1 0 |a Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis  |c D. Adams, A. Gonzalez-Duarte, W.D. O’Riordan, C.-C. Yang, M. Ueda, A.V. Kristen, I. Tournev, H.H. Schmidt, T. Coelho, J.L. Berk, K.-P. Lin, G. Vita, S. Attarian, V. Planté-Bordeneuve, M.M. Mezei, J.M. Campistol, J. Buades, T.H. Brannagan III, B.J. Kim, J. Oh, Y. Parman, Y. Sekijima, P.N. Hawkins, S.D. Solomon, M. Polydefkis, P.J. Dyck, P.J. Gandhi, S. Goyal, J. Chen, A.L. Strahs, S.V. Nochur, M.T. Sweetser, P.P. Garg, A.K. Vaishnaw, J.A. Gollob, and O.B. Suhr 
264 1 |c July 5, 2018 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 07.05.2019 
520 |a Original Article from The New England Journal of Medicine - Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis 
700 1 |a Kristen, Arnt  |d 1974-  |e VerfasserIn  |0 (DE-588)123480965  |0 (DE-627)706314530  |0 (DE-576)293726876  |4 aut 
773 0 8 |i Enthalten in  |t The New England journal of medicine  |d Waltham, Mass. : MMS, 1928  |g 379(2018), 1, Seite 11-21  |h Online-Ressource  |w (DE-627)266889484  |w (DE-600)1468837-2  |w (DE-576)075962454  |x 1533-4406  |7 nnas  |a Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis 
773 1 8 |g volume:379  |g year:2018  |g number:1  |g pages:11-21  |g extent:11  |a Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis 
856 4 0 |u https://doi.org/10.1056/NEJMoa1716153  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://www.nejm.org/doi/10.1056/NEJMoa1716153  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190423 
993 |a Article 
994 |a 2018 
998 |g 123480965  |a Kristen, Arnt  |m 123480965:Kristen, Arnt  |d 910000  |d 910100  |e 910000PK123480965  |e 910100PK123480965  |k 0/910000/  |k 1/910000/910100/  |p 6 
999 |a KXP-PPN1663508445  |e 3453020340 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedDisp":"July 5, 2018","dateIssuedKey":"2018"}],"recId":"1663508445","name":{"displayForm":["D. Adams, A. Gonzalez-Duarte, W.D. O’Riordan, C.-C. Yang, M. Ueda, A.V. Kristen, I. Tournev, H.H. Schmidt, T. Coelho, J.L. Berk, K.-P. Lin, G. Vita, S. Attarian, V. Planté-Bordeneuve, M.M. Mezei, J.M. Campistol, J. Buades, T.H. Brannagan III, B.J. Kim, J. Oh, Y. Parman, Y. Sekijima, P.N. Hawkins, S.D. Solomon, M. Polydefkis, P.J. Dyck, P.J. Gandhi, S. Goyal, J. Chen, A.L. Strahs, S.V. Nochur, M.T. Sweetser, P.P. Garg, A.K. Vaishnaw, J.A. Gollob, and O.B. Suhr"]},"relHost":[{"language":["eng"],"note":["Gesehen am 04.08.25","Volltext auch als Teil einer Datenbank verfügbar"],"titleAlt":[{"title":"NEJM"}],"corporate":[{"display":"Massachusetts Medical Society","role":"isb"}],"part":{"text":"379(2018), 1, Seite 11-21","extent":"11","volume":"379","issue":"1","pages":"11-21","year":"2018"},"physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"subtitle":"NEJM","title_sort":"New England journal of medicine","title":"The New England journal of medicine"}],"origin":[{"dateIssuedKey":"1928","dateIssuedDisp":"1928-","publisher":"MMS ; MMS","publisherPlace":"Waltham, Mass. ; Boston, Mass."}],"name":{"displayForm":["Massachusetts Medical Society"]},"recId":"266889484","id":{"issn":["1533-4406"],"eki":["266889484"],"zdb":["1468837-2"]},"disp":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosisThe New England journal of medicine","pubHistory":["198.1928 -"]}],"person":[{"given":"David B.","role":"aut","display":"Adams, David B.","family":"Adams"},{"family":"Kristen","given":"Arnt","display":"Kristen, Arnt","role":"aut"}],"note":["Gesehen am 07.05.2019"],"language":["eng"],"title":[{"title_sort":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis"}],"physDesc":[{"extent":"11 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.1056/NEJMoa1716153"],"eki":["1663508445"]}} 
SRT |a ADAMSDAVIDPATISIRANA5201 

Similar Items